Experimental combo therapy targets hard-to-treat sarcoma

This study tested a two-step treatment for people with advanced soft tissue sarcoma that had stopped responding to standard therapy. First, a drug called LTX-315 was injected into a tumor to attract immune cells. Then, that tumor was removed, and the immune cells were grown in a lab and infused back into the patient. The goal was to see if this approach was safe and could boost the body's immune attack on the cancer. Only 6 people took part, and the study focused on measuring immune cell changes and side effects.